Wednesday June 20th, 2018 7:06PM

US clears breakthrough gene therapy for childhood leukemia

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — Opening a new era in cancer care, U.S. health officials have approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.

The Food and Drug Administration said the approval on Wednesday was historic, the first gene therapy to hit the U.S. market. Made from scratch for every patient, it's one of a wave of "living drugs" under development to fight additional blood cancers and other tumors, too.

Novartis Pharmaceuticals set the price for its one-time infusion of so-called "CAR-T cells" at $475,000, but said there would be no charge for patients who didn't show a response within a month.

"This is a brand new way of treating cancer," said Dr. Stephan Grupp of Children's Hospital of Philadelphia, who treated the first child with CAR-T cell therapy — a girl who'd been near death but now is cancer-free for five years and counting. "That's enormously exciting."

CAR-T treatment uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer too often can evade. Researchers filter those cells from a patient's blood, reprogram them to harbor a "chimeric antigen receptor" or CAR that zeroes in on cancer, and grow hundreds of millions of copies. Returned to the patient, the revved-up cells can continue multiplying to fight disease for months or years.

It's a completely different way to harness the immune system than popular immunotherapy drugs called "checkpoint inhibitors" that treat a variety of cancers by helping the body's natural T cells better spot tumors. CAR-T cell therapy gives patients stronger T cells to do that job.

"We're entering a new frontier in medical innovation with the ability to reprogram a patient's own cells to attack a deadly cancer," said FDA Commissioner Scott Gottlieb.

The first CAR-T version, developed by Novartis and the University of Pennsylvania, is approved for use by several hundred patients a year who are desperately ill with acute lymphoblastic leukemia, or ALL. It strikes more than 3,000 children and young adults in the U.S. each year and while most survive, about 15 percent relapse despite today's best treatments.

In a key study of 63 advanced patients, 83 percent went into remission soon after receiving the CAR-T cells. Importantly, it's not clear how long that benefit lasts: Some patients did relapse months later. The others still are being tracked to see how they fare long-term.

Still, "a far higher percentage of patients go into remission with this therapy than anything else we've seen to date with relapsed leukemia," said Dr. Ted Laetsch of the University of Texas Southwestern Medical Center, one of the study sites. "I wouldn't say we know for sure how many will be cured yet by this therapy. There certainly is a hope" that some will be.

Most patients suffered side effects that can be grueling, even life-threatening. An immune overreaction called "cytokine release syndrome" can trigger high fevers, plummeting blood pressure and in severe cases organ damage, side effects that require sophisticated care to help patients without blocking the cancer attack. The FDA designated a treatment for those side effects Wednesday.

"This is remarkable technology," said Dr. Mikkael Sekeres of the American Society of Hematology. But, he cautioned that CAR-T "isn't a panacea."

Among concerns, sometimes leukemia can develop resistance, and sometimes patients worsen while waiting for their new cells, said Sekeres, who directs the Cleveland Clinic's leukemia program and wasn't involved with CAR-T testing.

"Unfortunately leukemia grows so rapidly that it can evade even the smartest of our technologies," he added.

To better ensure patient safety, the FDA is requiring Novartis to offer CAR-T therapy only through medical centers specially trained and certified to handle the complicated treatment. Novartis expects to have 32 centers around the country, mostly in large cities, running by year's end, with the first 20 offering care within the next month.

Patients' collected immune cells will be frozen and shipped to a Novartis factory in New Jersey that creates each dose, a process the company says should take about three weeks. The $475,000 price tag doesn't include the cost of needed hospitalizations, travel to a certified hospital and other expenses.

On a conference call Wednesday, Novartis executives said the company is working with the Medicaid program and private insurers and expects broad coverage, and will offer some financial assistance with such things as copay and travel costs. But they didn't promise all patients would be able to get the therapy.

For some patients, the new CAR-T therapy might replace bone marrow transplants that cost more than half a million dollars, noted Grupp, who led the Novartis study.

"I don't want to be an apologist for high drug prices in the U.S.," Grupp stressed. But if it's the last treatment they need, "that's a really significant one-time investment in their wellness, especially in kids who have a whole lifetime ahead of them."

"This is a turning point in the fight" against ALL, said Penn's Dr. Carl June, who pioneered the therapy.

But he and other researchers say thousands more patients eventually may benefit. Kite Pharma's similar CAR-T brand, developed by the National Cancer Institute, is expected to win approval later this year to treat aggressive lymphoma, and Juno Therapeutics and other companies are studying their own versions against blood cancers including multiple myeloma.

Scientists around the country also are trying to make CAR-T therapies that could fight more common solid tumors such as brain, breast or pancreatic cancers — a harder next step.

"Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of cancers. "Approvals are an important step, but they're just the beginning."


AP Medical Writer Linda A. Johnson in Trenton, New Jersey, contributed to this report.


This Associated Press series was produced in partnership with the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Local/State News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Online Headlines - Washington, AP Health, AP Health - Children's Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care, AP Technology News
© Copyright 2018
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
US clears breakthrough gene therapy for childhood leukemia
The U.S. has cleared a breakthrough cancer treatment that uses gene therapy to turn patients' own blood cells into assassins that attack childhood leukemia
5:26PM ( 3 minutes ago )
Groups sue to protect Yellowstone bears as hunts anticipated
Wildlife advocates and a Montana Indian tribe are asking a U.S. court to restore protections for grizzly bears in and around Yellowstone National Park so that trophy hunting of the fearsome animals wouldn't be allowed
5:24PM ( 5 minutes ago )
The Latest: Bowling alley helps victims, including a monkey
Among the places to open their doors to victims of Harvey's flooding is a bowling alley in the coastal Texas city of Port Arthur
5:16PM ( 13 minutes ago )
Associated Press (AP)
Floodwaters drop in Houston as Harvey takes a second swipe
Emergency officials say Harvey's floodwaters are beginning to drop across much of the Houston area
4:57PM ( 32 minutes ago )
The Latest: Mississippi homes damaged by Harvey tornado
Tropical Storm Harvey has spawned at least one tornado in Mississippi and created bands of strong winds that damaged homes and toppled some trees
4:46PM ( 43 minutes ago )
The Latest: EPA waives some clean-air rules due to Harvey
Authorities in Houston have been stressing that people will not be questioned about their immigration status at Harvey flood shelters
4:34PM ( 56 minutes ago )
AP National News
US clears first 'living drug' for tough childhood leukemia
Opening a new era in cancer care, the Food and Drug Administration has approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia
12:44PM ( 4 hours ago )
Troubled Indian hospital says 217 children died in August
A government hospital in northern India where dozens of babies died within two days earlier this month says at least 217 children have died during the month of August for a variety of reasons including an encephalitis outbreak
6:42AM ( 10 hours ago )
Prosecutors expect to charge German nurse with more killings
German prosecutors say they expect to bring new charges against a nurse serving a life sentence for two murders after determining he might have killed another 84 people, if not more
9:48AM ( 1 day ago )
AP Health
Colorado bus aide sentenced for assaulting autistic student
A former Colorado school bus aide who pleaded guilty to assaulting an autistic student on his way to and from school was sentenced to 20 months in jail
4:58PM ( 5 days ago )
FDA OKs Pfizer drug for rare, fast-killing type of leukemia
FDA approves new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed
5:35PM ( 1 week ago )
35 children die in north Indian hospital in 3 days
Parents of at least 35 children who have died in a state-run hospital in northern India over the past three days have alleged that the fatalities were due to the lack of a sufficient oxygen supply in the children's ward
12:44PM ( 2 weeks ago )
AP Health - Children's Health
EPA grants fuel waivers for Gulf Coast, Southeastern states
The Environmental Protection Agency has issued emergency waivers allowing states from Maryland to Texas to ignore some clean-air requirements for gasoline to ensure an adequate fuel supply despite disruptions caused by Harvey
4:52PM ( 37 minutes ago )
The Latest: Interior drops probe into secretary, senators
The Interior Department inspector general's office has dropped an investigation into whether the Trump administration pressured Alaska GOP Sens. Lisa Murkowski and Dan Sullivan over their health care votes
4:28PM ( 1 hour ago )
Kremlin confirms Trump's lawyer reached out about deal
The Kremlin has confirmed that President Donald Trump's personal lawyer has reached out to them during the 2016 presidential campaign, seeking help for a business project in Russia
3:46PM ( 1 hour ago )
AP Business
Former monk sues cosmetics giant over anti-aging formula
A former Roman Catholic monk has filed a federal lawsuit against cosmetics giant L'Oreal, accusing the company of stealing patented technology in an anti-aging wrinkle cream that his Massachusetts charity was selling to raise money for the poor
12:17PM ( 5 hours ago )
Stocks are mixed as tech companies rise and energy falls
US stocks are little changed as technology companies rise, helped by strong earnings from chipmaker Analog Devices, while energy companies fall
10:20AM ( 7 hours ago )
The Latest: Saudi-owned Motiva closes Port Arthur refinery
Motiva Enterprises has closed its refinery in Port Arthur, Texas _ the biggest in the nation _ because of floodwaters that are inundating the area east of Houston near the Louisiana border
9:59AM ( 7 hours ago )
AP Business - Corporate News
The Latest: Harvey death count up to 21, woman's body found
A woman whose body was found floating in floodwaters near a residential area in southeast Texas is believed to be at least the 21st person to have died in Harvey's path
3:01PM ( 2 hours ago )
The Latest: Forecasters watch system off Mexico coast
Forecasters are looking at a weather system off the Mexican coast just south of Texas that they say has a one-in-five chance of developing into something tropical in the next five days
2:54PM ( 2 hours ago )
The Latest: Death row inmate gets reprieve because of Harvey
A 36-year-old inmate scheduled for execution in Texas next week has been granted a temporary reprieve because of Harvey
2:41PM ( 2 hours ago )
AP Business - Industries
NFL making $40 million available for medical research
A year after the NFL pledged $100 million in support of independent medical research and engineering advancements, a huge chunk of that soon will be awarded to such research, primarily dedicated to neuroscience
2:38AM ( 1 day ago )
Gov't probe: Abuse in nursing homes unreported despite law
Gov't probe: A government audit finds that more than 1 in 4 cases of possible sexual and physical abuse against nursing home patients apparently went unreported to police.
2:10PM ( 2 days ago )
Massachusetts hospital worker claims record lottery jackpot
Largest undivided lottery prize in U.S. history claimed by Massachusetts hospital worker
5:54PM ( 5 days ago )
AP Business - Health Care
Groups sue to protect Yellowstone bears as hunts anticipated
Wildlife advocates and a Montana Indian tribe are asking a U.S. court to restore protections for grizzly bears in and around Yellowstone National Park so that trophy hunting of the fearsome animals wouldn't be allowed
5:24PM ( 5 minutes ago )
The Latest: Bowling alley helps victims, including a monkey
Among the places to open their doors to victims of Harvey's flooding is a bowling alley in the coastal Texas city of Port Arthur
5:16PM ( 13 minutes ago )
Brewers hold off Cardinals for 6-5 victory
Domingo Santana and Jonathan Villar homered in the sixth inning, and center fielder Keon Broxton made a leaping catch over the wall for the final out in the Milwaukee Brewers' 6-5 win over the St. Louis Cardinals
5:13PM ( 16 minutes ago )
The Latest: 2 more deaths brings Harvey toll to 23
Authorities say a married couple who drove their pickup truck into Harvey's floodwaters has drowned after the current from a nearby creek swept them away.
5:09PM ( 20 minutes ago )
AP FACT CHECK: Texas GOP misstates Sandy aid package
AP FACT CHECK: Texas GOP misstates Sandy aid package
5:09PM ( 21 minutes ago )